Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease: The EPOCA Randomized Clinical Trial

NCT06930885 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.

NCT NCT06930885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06930885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease: The EPOCA Randomized Clinical Trial
Lead sponsor
Hospital do Coracao
Phase
Phase 3
Overall status
Recruiting
Start date
June 12, 2025
Completion date
May 31, 2031
Enrollment
7,713 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease (ascvd), atherothrombotic diseases